Cas no 51439-63-5 (1-methoxynaphthalene-2-carbonyl chloride)

1-methoxynaphthalene-2-carbonyl chloride structure
51439-63-5 structure
Product Name:1-methoxynaphthalene-2-carbonyl chloride
CAS No:51439-63-5
MF:C12H9ClO2
MW:220.65166258812
CID:4013986
PubChem ID:13351908
Update Time:2025-04-24

1-methoxynaphthalene-2-carbonyl chloride Chemical and Physical Properties

Names and Identifiers

    • 2-Naphthalenecarbonyl chloride, 1-methoxy-
    • 1-methoxynaphthalene-2-carbonyl chloride
    • QMUUPQGZXWQYED-UHFFFAOYSA-N
    • DB-216146
    • 1-methoxy-2-naphthoyl chloride
    • SCHEMBL2747356
    • 51439-63-5
    • Inchi: 1S/C12H9ClO2/c1-15-11-9-5-3-2-4-8(9)6-7-10(11)12(13)14/h2-7H,1H3
    • InChI Key: QMUUPQGZXWQYED-UHFFFAOYSA-N
    • SMILES: C(Cl)(C1=CC=C2C(=C1OC)C=CC=C2)=O

Computed Properties

  • Exact Mass: 220.0291072Da
  • Monoisotopic Mass: 220.0291072Da
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 2
  • Heavy Atom Count: 15
  • Rotatable Bond Count: 2
  • Complexity: 242
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 3.7
  • Topological Polar Surface Area: 26.3?2

1-methoxynaphthalene-2-carbonyl chloride Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Alichem
A219001290-250mg
1-Methoxynaphthalene-2-carbonyl chloride
51439-63-5 98%
250mg
$666.40 2023-09-01
Alichem
A219001290-500mg
1-Methoxynaphthalene-2-carbonyl chloride
51439-63-5 98%
500mg
$1048.60 2023-09-01
Alichem
A219001290-1g
1-Methoxynaphthalene-2-carbonyl chloride
51439-63-5 98%
1g
$1701.85 2023-09-01
Enamine
BBV-45152333-1.0g
1-methoxynaphthalene-2-carbonyl chloride
51439-63-5 95%
1.0g
$1117.0 2023-01-08
Enamine
BBV-45152333-2.5g
1-methoxynaphthalene-2-carbonyl chloride
51439-63-5 95%
2.5g
$2316.0 2023-10-28
Enamine
BBV-45152333-5.0g
1-methoxynaphthalene-2-carbonyl chloride
51439-63-5 95%
5.0g
$2933.0 2023-01-08
Enamine
BBV-45152333-10.0g
1-methoxynaphthalene-2-carbonyl chloride
51439-63-5 95%
10.0g
$3687.0 2023-01-08
Enamine
BBV-45152333-1g
1-methoxynaphthalene-2-carbonyl chloride
51439-63-5 95%
1g
$1117.0 2023-10-28
Enamine
BBV-45152333-5g
1-methoxynaphthalene-2-carbonyl chloride
51439-63-5 95%
5g
$2933.0 2023-10-28
Enamine
BBV-45152333-10g
1-methoxynaphthalene-2-carbonyl chloride
51439-63-5 95%
10g
$3687.0 2023-10-28

Additional information on 1-methoxynaphthalene-2-carbonyl chloride

Compound CAS No. 51439-63-5: 2-Naphthalenecarbonyl Chloride, 1-Methoxy

The compound with CAS No. 51439-63-5, commonly referred to as 2-Naphthalenecarbonyl Chloride, 1-Methoxy, is a highly specialized organic compound that has garnered significant attention in the fields of organic chemistry and materials science. This compound is characterized by its unique structure, which combines the naphthalene moiety with a methoxy group and a carbonyl chloride functional group. The naphthalene framework provides a rigid aromatic system, while the methoxy group introduces electron-donating properties, and the carbonyl chloride group imparts reactivity, making this compound versatile for various applications.

Recent studies have highlighted the potential of 2-Naphthalenecarbonyl Chloride, 1-Methoxy in advanced materials synthesis, particularly in the development of high-performance polymers and organic electronics. Researchers have explored its ability to act as a building block for constructing conjugated systems, which are essential for applications such as light-emitting diodes (LEDs) and photovoltaic devices. The compound's reactivity has been leveraged in nucleophilic acyl substitution reactions, enabling the creation of tailored polymers with enhanced electronic properties.

In addition to its role in materials science, 2-Naphthalenecarbonyl Chloride, 1-Methoxy has shown promise in medicinal chemistry. Its structure has been utilized as a precursor for bioactive molecules, where the naphthalene core serves as a scaffold for drug design. Recent research has focused on its potential as an intermediate in the synthesis of kinase inhibitors and other therapeutic agents. The compound's ability to undergo selective substitution reactions has made it a valuable tool in drug discovery pipelines.

The synthesis of 2-Naphthalenecarbonyl Chloride, 1-Methoxy involves a multi-step process that typically begins with the methylation of naphthalene derivatives followed by chlorination to introduce the carbonyl chloride group. Optimization of these steps has been a focus of recent studies, with researchers exploring greener synthetic routes that minimize environmental impact while maintaining high yields and purity.

From an analytical standpoint, the characterization of 2-Naphthalenecarbonyl Chloride, 1-Methoxy has been enhanced by modern spectroscopic techniques such as nuclear magnetic resonance (NMR) and mass spectrometry (MS). These methods have provided deeper insights into its molecular structure and reactivity, facilitating its application in complex chemical transformations.

In conclusion, 2-Naphthalenecarbonyl Chloride, 1-Methoxy (CAS No. 51439-63-5) stands out as a versatile compound with significant potential across multiple disciplines. Its unique combination of structural features and reactivity positions it as a valuable tool in advancing materials science and medicinal chemistry research.

Recommended suppliers
PRIBOLAB PTE.LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
PRIBOLAB PTE.LTD
ASIACHEM I&E (JIANGSU) CO., LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
ASIACHEM I&E (JIANGSU) CO., LTD
Shenzhen Jianxing Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shenzhen Jianxing Pharmaceutical Technology Co., Ltd.
鉅瀾化工科技(青島)有限公司
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
鉅瀾化工科技(青島)有限公司
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.